This result is in agreement with other studies on the association of high-level PD-1 expression with the clinical features of multiple tumors including CRC, hepatocellular carcinoma, esophageal cancer, and kidney clear cell carcinoma [21,26,49,50,51,59]. This evidence concerns the gene PDCD1 and esophageal cancer.